Previous 10 | Next 10 |
DURECT Corporation Appoints Timothy M. Papp as Chief Financial Officer PR Newswire CUPERTINO, Calif. , July 5, 2022 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX), a biopharmaceutical company focused on epigenetic regulation to develop treatmen...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Athersys ( ATHX ) stock tops our gainers today on clinical trial news. Symbotic (NASDAQ: SYM ) leads our losers after its market debut yesterday. Earnings and other data have more shares on the move this mo...
DURECT Corporation to Present at the H.C. Wainwright Global Investment Conference PR Newswire CUPERTINO, Calif. , May 18, 2022 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that Dr. James E. Brown , President and CEO, Dr. Nor...
DURECT Corp, Inc. (DRRX) Q1 2022 Earnings Conference Call May 04, 2022, 16:30 ET Company Participants Matthew Hogan - IR James Brown - Co-Founder, CEO, President & Director Norman Sussman - Chief Medical Officer Conference Call Participants François Brisebois - Oppenheimer Thomas Yip...
Durect press release (NASDAQ:DRRX): Q1 GAAP EPS of -$0.05 in-line. Revenue of $1.92M (-13.1% Y/Y) misses by $0.36M. For further details see: Durect GAAP EPS of -$0.05 in-line, revenue of $1.92M misses by $0.36M
DURECT Corporation Reports First Quarter 2022 Financial Results and Update of Programs PR Newswire - Webcast of Earnings Call Today, May 4 th at 4:30 p.m. ET - Adding new clinical sites and patient dosing progressing in the AHFIRM trial ...
DURECT Corporation to Announce First Quarter 2022 Financial Results and Provide Business Update on May 4 PR Newswire CUPERTINO, Calif. , April 27, 2022 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that it will report its first qua...
DURECT Corporation To Present at the 2022 Cantor Fitzgerald Virtual Rare Orphan Disease Summit PR Newswire CUPERTINO, Calif. , March 23, 2022 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that Dr. James E. Brown , President and CEO, wi...
DURECT Corporation Fireside Chat at the Oppenheimer 32nd Annual Healthcare Conference PR Newswire CUPERTINO, Calif. , March 9, 2022 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that Dr. James E. Brown , President and CEO, Dr. WeiQi ...
DURECT Corporation (DRRX) Q4 2021 Earnings Conference Call March 7, 2022, 4:30 PM ET Company Participants Mike Arenberg - Chief Financial Officer Matt Hogan - Former Chief Financial Officer Jim Brown - President and CEO Dr. WeiQi Lin - Executive Vice President, R&D and Principal Scientist...
News, Short Squeeze, Breakout and More Instantly...
DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis PR Newswire DURECT plans to confirm the efficacy and safety of larsucosterol in a registrational Phase 3 clinical trial CUPERTINO, Calif. , May ...
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 171.6% to $0.1657 on volume of 180,907,472 shares AMC Entertainment Holdings Inc. Class A (AMC) rose 84.4% to $9.57 on volume of 174,658,682 shares Plug Power Inc. (PLUG) rose 45.9%...
DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update PR Newswire - FDA Feedback Supports Single Pivotal Trial for Approval of Larsucosterol in Alcohol-Associated Hepatitis - Webcast of Ea...